StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Biogen (BIIB)

Biogen (BIIB) PT Lowered to $352 at Morgan Stanley January 19, 2021 2:34 AM - StreetInsider Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone January 11, 2021 7:30 AM - Globe NewsWire Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone January 11, 2021 7:30 AM - StreetInsider Biogen (BIIB) Climbs 9% Pre-Open, Possibly in Sympathy with Lilly (LLY) Following Alzheimer's Data January 11, 2021 6:37 AM - StreetInsider Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases January 11, 2021 6:00 AM - BizWire DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm January 8, 2021 9:00 PM - StreetInsider Biogen (BIIB) Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA in Patients Treated With Zolgensma January 8, 2021 7:31 AM - StreetInsider Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec) January 8, 2021 7:30 AM - Globe NewsWire Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec) January 8, 2021 7:30 AM - StreetInsider SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Files Securities Class Action Lawsuit Against Biogen Inc. on Behalf of Investors Who Acquired Shares from October 22, 2019 to November 6, 2020 and Encourages January 5, 2021 7:38 PM - StreetInsider ViGeneron signs global collaboration agreement for ophthalmic gene therapy development January 5, 2021 2:00 AM - Globe NewsWire SAGE Therapeutics (SAGE) Receives $875M Upfront Payment from Biogen (BIIB), Sells 6.24M Shares at $104.14 December 31, 2020 4:11 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Interface, Cabot Oil & Gas, Biogen, and Stride and Encourages Investors to Contact the Firm December 29, 2020 5:00 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Stride, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm December 22, 2020 6:00 PM - StreetInsider Biogen (BIIB) Announces EC Grants Marketing Authorization for PLEGRIDY Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis December 21, 2020 7:31 AM - StreetInsider The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis December 21, 2020 7:30 AM - Globe NewsWire The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis December 21, 2020 7:30 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Biogen, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm December 16, 2020 7:00 PM - StreetInsider APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development December 15, 2020 7:00 PM - PR NewsWire DEADLINE ALERT for BABA, BIIB, YY, LRN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders December 10, 2020 11:30 AM - PR NewsWire Biogen Files New Drug Application for Aducanumab in Japan December 9, 2020 10:30 PM - Globe NewsWire Biogen Files New Drug Application for Aducanumab in Japan December 9, 2020 10:30 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Biogen, JOYY, and Berry Corporation and Encourages Investors to Contact the Firm December 9, 2020 8:00 PM - StreetInsider Form SC 13G/A BIOGEN INC. Filed by: PRIMECAP MANAGEMENT CO/CA/ December 9, 2020 5:01 PM - SEC Filing Form 4 BIOGEN INC. For: Dec 03 Filed by: Kramer Robin December 7, 2020 9:09 PM - SEC Filing Form 4 BIOGEN INC. For: Dec 01 Filed by: Guindo Chirfi December 3, 2020 5:41 PM - SEC Filing New Coalition Aims To Close The Opportunity Gap In Bioscience December 3, 2020 8:00 AM - BizWire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, JOYY, Berry Corporation, and Pinterest and Encourages Investors to Contact the Firm December 2, 2020 9:00 PM - StreetInsider Biogen (BIIB) CEO Buys 3,100 Shares December 1, 2020 5:10 PM - StreetInsider Form 4 BIOGEN INC. For: Nov 30 Filed by: Vounatsos Michel December 1, 2020 4:57 PM - SEC Filing UPDATE: Biogen (BIIB) PT Raised to $256 at RBC Capital After SAGE Deal Call December 1, 2020 6:13 AM - StreetInsider Pre-Open Stock Movers 11/27: (SRNE) (WYY) (APXT) (PLTR) (MARA) (more...) November 27, 2020 9:05 AM - StreetInsider Biogen (BIIB) and Sage Therapeutics (SAGE) Announce Pact to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders November 27, 2020 7:31 AM - StreetInsider Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders November 27, 2020 7:30 AM - BizWire Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders November 27, 2020 7:30 AM - Globe NewsWire Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders November 27, 2020 7:30 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm November 24, 2020 8:00 PM - StreetInsider ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment November 23, 2020 4:00 AM - PR NewsWire Biogen (BIIB) PT Raised to $249 at RBC Capital November 19, 2020 6:27 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm November 18, 2020 9:00 PM - StreetInsider Samsung Bioepis and Biogen (BIIG) Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis November 18, 2020 7:02 AM - StreetInsider Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab) November 18, 2020 7:00 AM - Globe NewsWire Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab) November 18, 2020 7:00 AM - StreetInsider Buffett's Berkshire Hathaway Enters AbbVie (ABBV), Bristol-Myers (BMY), Merck (MRK), Pfizer (PFE), T-Mobile (TMUS) - 13F November 16, 2020 4:10 PM - StreetInsider Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership November 16, 2020 7:30 AM - Globe NewsWire Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership November 16, 2020 7:30 AM - StreetInsider BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm November 13, 2020 8:00 PM - StreetInsider BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen, Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm November 12, 2020 8:00 PM - StreetInsider Increasing unusual put option volume: ERIC ACB REV DHI EWG ABR DDOG BIIB November 11, 2020 10:18 AM - StreetInsider Biogen (BIIB) PT Raised to $443 at Truist Securities November 10, 2020 7:53 AM - StreetInsider DZ Bank Upgrades Biogen (BIIB) to Buy November 10, 2020 4:33 AM - StreetInsider Stocks with Implied Volatility Movement November 10, 2020 4:20 AM - StreetInsider Biogen (BIIB) IV comes in, shares down 29% after results of FDA advisory committee voting November 9, 2020 12:35 PM - StreetInsider Pre-Open Stock Movers 11/9: (AMC) (CNK) (CCL) Higher; (BIIB) (QDEL) (PTON) Lower (more...) November 9, 2020 9:32 AM - StreetInsider Biogen (BIIB) Stock Crashes 30% As FDA Tears Down Alzheimer's Treatment, Prompting Multiple Downgrades November 9, 2020 8:53 AM - StreetInsider Biogen plunges 30% after FDA panel votes against Alzheimer's drug November 9, 2020 8:06 AM - StreetInsider Energy, travel stocks surge on Pfizer vaccine hopes November 9, 2020 7:37 AM - StreetInsider Biogen (BIIB) Resumes Trading, Down 31% November 9, 2020 7:10 AM - StreetInsider Biogen (BIIB) to Resume Trading at 7:10 a.m. After FDA Panel's Negative Vote on Potential Treatment for Alzheimer’s Disease November 9, 2020 6:46 AM - StreetInsider Biogen (BIIB) Confirms Negative FDA Advisory Committee Votes on Aducanumab in Alzheimer's Disease November 9, 2020 6:41 AM - StreetInsider Biogen (BIIB) PT Lowered to $244 at Mizuho Securities November 9, 2020 6:32 AM - StreetInsider BofA Securities Downgrades Biogen (BIIB) to Underperform November 9, 2020 6:18 AM - StreetInsider Cowen Downgrades Biogen (BIIB) to Market Perform November 9, 2020 6:18 AM - StreetInsider Biogen (BIIB) PT Lowered to $338 at Wells Fargo November 9, 2020 5:50 AM - StreetInsider Stocks expected to have increasing option volume: BIIB ACB TLRY CRON HEXO November 9, 2020 5:26 AM - StreetInsider Biogen (BIIB) IV elevated into results of FDA advisory committee voting November 9, 2020 4:53 AM - StreetInsider Biogen (BIIB) IV elevated into results of FDA advisory committee voting November 9, 2020 4:40 AM - StreetInsider Biogen (BIIB) PT Lowered to $382 at SVB Leerink November 9, 2020 4:39 AM - StreetInsider Atlantic Equities Downgrades Biogen (BIIB) to Underweight November 9, 2020 3:47 AM - StreetInsider Form 4 BIOGEN INC. For: Nov 04 Filed by: Sandrock Alfred November 6, 2020 9:40 PM - SEC Filing Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease November 6, 2020 8:15 PM - Globe NewsWire Biogen (BIIB) IV into FDA panel to discuss Biogen Alzheimer's application and vote November 6, 2020 7:50 PM - StreetInsider Biotech ETF (IBB) Lower After Biogen (BIIB) FDA Panel Negative Vote on Question 1 November 6, 2020 3:23 PM - StreetInsider Biogen (BIIB) Study Fails to Show Alzheimer's Effectiveness, Says FDA Panel November 6, 2020 3:19 PM - StreetInsider Biogen (BIIB) Halted, News Pending November 6, 2020 6:56 AM - StreetInsider Stocks expected to have increasing option volume: NET UBER BMY ZTS BIIB MTCH November 6, 2020 4:34 AM - StreetInsider Biogen (BIIB) option implied volatility elevated after sharp rally into FDA panel November 5, 2020 10:44 AM - StreetInsider Increasing unusual put option volume: WMGI BKLN RSX MTCH ZNGA ELAN XME KKR BIIB WEN November 5, 2020 4:22 AM - StreetInsider Stocks with Implied Volatility Movement November 5, 2020 4:15 AM - StreetInsider Biogen (BIIB) PT Raised to $402 at SVB Leerink November 5, 2020 4:12 AM - StreetInsider BofA Securities Upgrades Biogen (BIIB) to Neutral November 4, 2020 3:15 PM - StreetInsider Jefferies Upgrades Biogen (BIIB) to Buy November 4, 2020 1:09 PM - StreetInsider Biogen (BIIB) Risk/Reward Now Skewed to Downside After Big Move Higher - Mizuho November 4, 2020 12:50 PM - StreetInsider Biogen (BIIB) call put ratio 1.7 calls to 1 put with focus as shares rally 39% November 4, 2020 12:34 PM - StreetInsider Cowen Said FDA Briefing Docs on Biogen (BIIB) Adu 'Not Without Controversy', Citing Statistical Reviewer November 4, 2020 11:25 AM - StreetInsider Biogen (BIIB) Adu Briefing Docs Were Positive, Approval Could Lead to 30-50% Upside - Guggenheim November 4, 2020 11:11 AM - StreetInsider Wells Fargo Upgrades Biogen (BIIB) to Overweight November 4, 2020 11:03 AM - StreetInsider FDA Giving Biogen (BIIB) Option for Aducanumab Approval on Efficacy from ENGAGE Trial, Shares Worth $443 on Approval - Truist November 4, 2020 10:54 AM - StreetInsider AC Immune SA (ACIU) Gains on Biogen Briefing Documents November 4, 2020 10:21 AM - StreetInsider Biogen (BIIB) Halted on LUDP November 4, 2020 10:12 AM - StreetInsider Biogen (BIIB) Spikes 14% After FDA Posts Briefing Documents for Alzheimer's Drug Aducanumab November 4, 2020 10:11 AM - StreetInsider Biogen (BIIB) option implied volatility elevated into FDA panel November 4, 2020 4:31 AM - StreetInsider Biogen (BIIB) option implied volatility increases into events November 3, 2020 11:20 AM - StreetInsider Biogen (BIIB) to Present Positive Phase 2 Systemic Lupus Erythematosus Data at ACR November 3, 2020 7:35 AM - StreetInsider Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting November 3, 2020 7:30 AM - Globe NewsWire Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting November 3, 2020 7:30 AM - StreetInsider U.S. experts to review Biogen drug that could be first new Alzheimer's treatment in decades November 3, 2020 6:20 AM - StreetInsider Biogen (BIIB) option prices elevated November 2, 2020 4:22 AM - StreetInsider Biogen (BIIB) Announces EMA Accepts Aducanumab Marketing Authorization Application for Alzheimer's Disease October 30, 2020 7:02 AM - StreetInsider European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease October 30, 2020 7:00 AM - Globe NewsWire European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease October 30, 2020 7:00 AM - StreetInsider Stocks with Implied Volatility Movement October 30, 2020 4:18 AM - StreetInsider Stocks with Implied Volatility Movement October 29, 2020 12:41 AM - StreetInsider UPDATE: Biogen (BIIB) Initiated at Neutral at UBS October 27, 2020 4:51 PM - StreetInsider Biogen (BIIB) Shares Looking 'Interesting' Into Big Week Ahead - Mizuho October 27, 2020 8:07 AM - StreetInsider Stocks with Implied Volatility Movement October 27, 2020 4:29 AM - StreetInsider Stocks with Implied Volatility Movement October 23, 2020 4:19 AM - StreetInsider Biogen (BIIB) PT Raised to $357 at Morgan Stanley October 22, 2020 8:11 AM - StreetInsider Biogen (BIIB) PT Lowered to $350 at Credit Suisse October 22, 2020 5:54 AM - StreetInsider Biogen (BIIB) PT Lowered to $265 at Barclays October 22, 2020 5:42 AM - StreetInsider Stocks with Implied Volatility Movement October 22, 2020 4:51 AM - StreetInsider Form 10-Q BIOGEN INC. For: Sep 30 October 21, 2020 5:18 PM - SEC Filing Biogen (BIIB) PT Lowered to $340 at Oppenheimer October 21, 2020 4:45 PM - StreetInsider Biogen (BIIB) PT Lowered to $258 at Stifel October 21, 2020 4:32 PM - StreetInsider Biogen (BIIB) PT Lowered to $310 at Truist Securities, Following Earnings October 21, 2020 3:54 PM - StreetInsider Form 8-K BIOGEN INC. For: Oct 21 October 21, 2020 7:22 AM - SEC Filing Biogen (BIIB) Tops Q3 EPS by 71c, Updates Guidance, Approves $5 Billion Buyback October 21, 2020 7:05 AM - StreetInsider Full Article List